Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration HHS
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA
Performance Review
 

Clinical Measures for Health Center Grantee Performance Reviews –
Calendar Year 2006


Performance Measure: # 4   Activity Code(s): H 80  
Percentage of Children 5 through 18 years of age diagnosed with “persistent” asthma, who were prescribed appropriate medications.
 
Operational Definition:
Numerator:

# of patients diagnosed with mild, moderate or severe persistent asthma, as per NHLBI guidelines, who at last contact, have been documented to be on anti-inflammatory medication (inhaled corticosteroids, mast cell stabilizers, leukotreine modifiers)

See: http://www.healthdisparities.net/hdc/html/collaboratives.topics.asthma.aspx
and: http://www.ncqa.org/Docs/SOHCQ_2005.pdf (page 50)

Denominator:

# of patients’ 5 through18 years of age with documented persistent asthma, and seen at least once at the health center for any cause during calendar year.

May use UDS Table 6, line 5, column b; or MIS system, or similar source.

Unit & Text: numerator count / denominator count x 100 = %
 

National Numeric Benchmark:

Health Disparities Collaborative has target goal of 95%, with an increase from 30% to 80% among collaborative participants. From 2000 to 2004, HEDIS shows an improvement from 57% to 64% among Medicaid programs and from 63% to 73% among Commercial programs
Data Sources
and Data Issues:

From registry or EHR/EMR if available.

If chart audit, then sample from the sample frame of persons meeting denominator criteria.
Denominator data should be readily available from MIS and encounter or discharge code, since reported for UDS and others. Numerator may or may not be readily available depending on whether participating in HEDIS reporting, internal QA, health disparities initiative. May require sampling and manual record abstraction by grantee’s QA Committee.

 
Background/significance of the measure:

Asthma, a chronic inflammatory disease of the airways is widely recognized as a concern by both the public and health professionals and government (HP2010 Goal 24-7). In 2003, some 20 million people or 8 percent of Americans were diagnosed with asthma. In 2002, asthma accounted for some 3 million hospital outpatient visits, 13 million doctor visits, 500,000 hospitalizations, and over 4,000 deaths.

Asthma is the leading cause of school absenteeism, causing children to miss an estimated 14 million school days annually. Asthma accounts for an estimated 14.5 million lost workdays for adults. The economic cost of asthma is $14 billion annually, including $4.6 billion in lost productivity. A 45 percent reduction in the risk of repeat Emergency Department visits was shown in patients using inhaled corticosteroid treatment compared with nonusers.

According to the UDS, this is the leading chronic disease condition in children cared for at health centers, and it is the third most prevalence condition among the people served by health centers in 2004. It is the best proxy measure for chronic disease in children, and a good measure for adults. Analysis of measure involves provider education, screening, diagnosis, follow-up, adherence to practice guidelines, and patient education.

For clinical practice guidelines for this measure:

For more about this measure: